APOE genotype and cognitive functioning in a large age-stratified population sample.
There is evidence that the cognitive effects of Alzheimer's disease can be seen decades before disease diagnosis. If this is the case, then the apolipoprotein E (APOE) *E4 allele might be expected to have effects on cognitive functioning earlier in the life span. To assess such effects, the authors examined data on the *E4 allele and cognitive functioning from a population sample of 6,560 Caucasians covering the age groups of 20-24, 40-44, and 60-64 years. Participants were assessed on tests of episodic memory, working memory, mental speed, reaction time, and reading vocabulary. Although performance on all tests except reading vocabulary declined across age groups, there was no effect of the APOE *E4 allele at any age. These results indicate that APOE *E4 does not have preclinical effects early in the life span on these cognitive functions. Cognitive aging effects between the ages of 20 and 64 years must not be due to preclinical Alzheimer's disease.
Jorm
Anthony F
AF
ORYGEN Research Centre, University of Melbourne, Parkville, VIC, Australia. ajorm@unimelb.edu.au
Mather
Karen A
KA
Butterworth
Peter
P
Anstey
Kaarin J
KJ
Christensen
Helen
H
Easteal
Simon
S
D000328:Adult; D000367:Age Factors; D053327:Apolipoprotein E4 / Q000235:genetics*; D003071:Cognition / Q000502:physiology*; D005260:Female; D005820:Genetic Testing / Q000379:methods; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D011446:Prospective Studies; D013057:Spectrum Analysis; D044465:White People
D053327:Apolipoprotein E4